Bladder cancer patients who are too frail for chemo offered hope as health chiefs approve drug

Bladder cancer patients who are too frail for chemo offered hope as health chiefs approve drug Thousands of NHS patients with deadly bladder cancer are set to benefit from a drug that offers fresh hope of a cure.

In a milestone ruling, UK health chiefs have approved nivolumab for sufferers who are too frail to withstand treatments such as chemotherapy.

Doctors usually give a course of chemotherapy after removing bladder tumours to kill off any remaining cancer cells. The Daily Mail